Skip to main content
PMC home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1996 Mar-Apr;69(2):159–174.

pH, healing rate and symptom relief in acid-related diseases.

J Q Huang 1, R H Hunt 1
PMCID: PMC2588990  PMID: 9112748

Abstract

Suppression of gastric acid secretion is widely used and logical for the treatment of acid-related diseases. Healing of duodenal ulcer, gastric ulcer and gastroesophageal reflux disease is correlated significantly with the degree and the duration of suppression of intragastric acidity over 24 hours and with the length of the treatment. To date, proton pump inhibitors are the most effective agents among the currently available antisecretory drugs in offering the highest healing rate and fastest resolution of symptoms. Combinations of an antisecretory drug with one or more antimicrobial agents accelerate healing of peptic ulcers.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D., Arnold R., Classen M., Fischer M., Goebell H., Blum A. L. Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group. Gut. 1993 Oct;34(10):1319–1326. doi: 10.1136/gut.34.10.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Axon A. T. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol Suppl. 1994;201:16–23. [PubMed] [Google Scholar]
  3. BARON J. H. The relationship between basal and maximum acid output in normal subjects and patients with duodenal ulcer. Clin Sci. 1963 Jun;24:357–370. [PubMed] [Google Scholar]
  4. Bader J. P., Delchier J. C. Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther. 1994;8 (Suppl 1):47–52. doi: 10.1111/j.1365-2036.1994.tb00247.x. [DOI] [PubMed] [Google Scholar]
  5. Bardhan K. D., Ahlberg J., Hislop W. S., Lindholmer C., Long R. G., Morgan A. G., Sjostedt S., Smith P. M., Stig R., Wormsley K. G. Rapid healing of gastric ulcers with lansoprazole. Aliment Pharmacol Ther. 1994 Apr;8(2):215–220. doi: 10.1111/j.1365-2036.1994.tb00281.x. [DOI] [PubMed] [Google Scholar]
  6. Bardhan K. D., Morris P., Thompson M., Dhande D. S., Hinchliffe R. F., Jones R. B., Daly M. J., Carroll N. J. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine. Gut. 1990 Jul;31(7):745–749. doi: 10.1136/gut.31.7.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bate C. M., Wilkinson S. P., Bradby G. V., Bateson M. C., Hislop W. S., Crowe J. P., Willoughby C. P., Peers E. M., Richardson P. D. Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut. 1989 Oct;30(10):1323–1328. doi: 10.1136/gut.30.10.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Battaglia G., Di Mario F., Dotto P., Leandro G., Pilotto A., Ferrana M., Vianello F., Vigneri S., Colonna C. V., Naccarato R. Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients. Dig Dis Sci. 1993 Aug;38(8):1414–1421. doi: 10.1007/BF01308597. [DOI] [PubMed] [Google Scholar]
  9. Beker J. A., Bianchi Porro G., Bigard M. A., Delle Fave G., Devis G., Gouerou H., Maier C. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995 May;7(5):407–410. [PubMed] [Google Scholar]
  10. Bell N. J., Burget D., Howden C. W., Wilkinson J., Hunt R. H. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51 (Suppl 1):59–67. doi: 10.1159/000200917. [DOI] [PubMed] [Google Scholar]
  11. Bell N. J., Hunt R. H. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut. 1992 Jan;33(1):118–124. doi: 10.1136/gut.33.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bendtsen F., Rosenkilde-Gram B., Tage-Jensen U., Ovesen L., Rune S. J. Duodenal bulb acidity in patients with duodenal ulcer. Gastroenterology. 1987 Dec;93(6):1263–1269. doi: 10.1016/0016-5085(87)90254-x. [DOI] [PubMed] [Google Scholar]
  13. Bianchi Porro G., Parente F., Lazzaroni M. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. Gut. 1993 Apr;34(4):466–469. doi: 10.1136/gut.34.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Boesby S. Relationship between gastro-oesophageal acid reflux, basal gastro-oesophageal sphincter pressure, and gastric acid secretion. Scand J Gastroenterol. 1977;12(5):547–551. doi: 10.3109/00365527709181333. [DOI] [PubMed] [Google Scholar]
  15. Bortolotti M., Abbati A., Turba E., Pozzato R., Bersani G., Labò G. 99mTc-HIDA dynamic scintigraphy for the diagnosis of gastroesophageal reflux of bile. Eur J Nucl Med. 1985;10(11-12):549–550. doi: 10.1007/BF00252750. [DOI] [PubMed] [Google Scholar]
  16. Burget D. W., Chiverton S. G., Hunt R. H. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990 Aug;99(2):345–351. doi: 10.1016/0016-5085(90)91015-x. [DOI] [PubMed] [Google Scholar]
  17. Caldwell M. T., Lawlor P., Byrne P. J., Walsh T. N., Hennessy T. P. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg. 1995 May;82(5):657–660. doi: 10.1002/bjs.1800820528. [DOI] [PubMed] [Google Scholar]
  18. Champion G., Richter J. E., Vaezi M. F., Singh S., Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology. 1994 Sep;107(3):747–754. doi: 10.1016/0016-5085(94)90123-6. [DOI] [PubMed] [Google Scholar]
  19. Delhotal-Landes B., Flouvat B., Duchier J., Molinie P., Dellatolas F., Lemaire M. Pharmacokinetics of lansoprazole in patients with renal or liver disease of varying severity. Eur J Clin Pharmacol. 1993;45(4):367–371. doi: 10.1007/BF00265957. [DOI] [PubMed] [Google Scholar]
  20. Dent J., Holloway R. H., Toouli J., Dodds W. J. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut. 1988 Aug;29(8):1020–1028. doi: 10.1136/gut.29.8.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Dragstedt L. R. Peptic ulcer. An abnormality in gastric secretion. Am J Surg. 1969 Feb;117(2):143–156. doi: 10.1016/0002-9610(69)90298-0. [DOI] [PubMed] [Google Scholar]
  22. Ekström P., Carling L., Unge P., Anker-Hansen O., Sjöstedt S., Sellström H. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study. Scand J Gastroenterol. 1995 Mar;30(3):210–215. doi: 10.3109/00365529509093265. [DOI] [PubMed] [Google Scholar]
  23. Endoh K., Leung F. W. Effects of smoking and nicotine on the gastric mucosa: a review of clinical and experimental evidence. Gastroenterology. 1994 Sep;107(3):864–878. doi: 10.1016/0016-5085(94)90138-4. [DOI] [PubMed] [Google Scholar]
  24. Eriksson S., Långström G., Rikner L., Carlsson R., Naesdal J. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eur J Gastroenterol Hepatol. 1995 May;7(5):467–475. [PubMed] [Google Scholar]
  25. Euler A. R., Murdock R. H., Jr, Wilson T. H., Silver M. T., Parker S. E., Powers L. Ranitidine is effective therapy for erosive esophagitis. Am J Gastroenterol. 1993 Apr;88(4):520–524. [PubMed] [Google Scholar]
  26. Feldman M., Harford W. V., Fisher R. S., Sampliner R. E., Murray S. B., Greski-Rose P. A., Jennings D. E. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group. Am J Gastroenterol. 1993 Aug;88(8):1212–1217. [PubMed] [Google Scholar]
  27. Feldman M., Richardson C. T. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy. Gastroenterology. 1986 Mar;90(3):540–544. doi: 10.1016/0016-5085(86)91106-6. [DOI] [PubMed] [Google Scholar]
  28. GROSSMAN M. I., KIRSNER J. B., GILLESPIE I. E. BASAL AND HISTALOG-STIMULATED GASTRIC SECRETION IN CONTROL SUBJECTS AND IN PATIENTS WITH PEPTIC ULCER OR GASTRIC CANCER. Gastroenterology. 1963 Jul;45:14–26. [PubMed] [Google Scholar]
  29. Gillen P., Keeling P., Byrne P. J., Healy M., O'Moore R. R., Hennessy T. P. Implication of duodenogastric reflux in the pathogenesis of Barrett's oesophagus. Br J Surg. 1988 Jun;75(6):540–543. doi: 10.1002/bjs.1800750612. [DOI] [PubMed] [Google Scholar]
  30. Gitlin N., McCullough A. J., Smith J. L., Mantell G., Berman R. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gastroenterology. 1987 Jan;92(1):48–53. doi: 10.1016/0016-5085(87)90838-9. [DOI] [PubMed] [Google Scholar]
  31. Gledhill T., Howard O. M., Buck M., Paul A., Hunt R. H. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer. Gut. 1983 Oct;24(10):904–908. doi: 10.1136/gut.24.10.904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Goldberg H. I., Dodds W. J., Gee S., Montgomery C., Zboralske F. F. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology. 1969 Feb;56(2):223–230. [PubMed] [Google Scholar]
  33. Gotley D. C., Morgan A. P., Ball D., Owen R. W., Cooper M. J. Composition of gastro-oesophageal refluxate. Gut. 1991 Oct;32(10):1093–1099. doi: 10.1136/gut.32.10.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gotley D. C., Morgan A. P., Cooper M. J. Bile acid concentrations in the refluxate of patients with reflux oesophagitis. Br J Surg. 1988 Jun;75(6):587–590. doi: 10.1002/bjs.1800750632. [DOI] [PubMed] [Google Scholar]
  35. Graham D. Y., Lew G. M., Evans D. G., Evans D. J., Jr, Klein P. D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991 Aug 15;115(4):266–269. doi: 10.7326/0003-4819-115-4-266. [DOI] [PubMed] [Google Scholar]
  36. Graham D. Y., Lew G. M., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Alpert L. C., Genta R. M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb;102(2):493–496. doi: 10.1016/0016-5085(92)90095-g. [DOI] [PubMed] [Google Scholar]
  37. Hawkey C. J., Long R. G., Bardhan K. D., Wormsley K. G., Cochran K. M., Christian J., Moules I. K. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine. Gut. 1993 Oct;34(10):1458–1462. doi: 10.1136/gut.34.10.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Helander H. F., Keeling D. J. Cell biology of gastric acid secretion. Baillieres Clin Gastroenterol. 1993 Mar;7(1):1–21. doi: 10.1016/0950-3528(93)90029-r. [DOI] [PubMed] [Google Scholar]
  39. Helm J. F. Esophageal acid clearance. J Clin Gastroenterol. 1986;8 (Suppl 1):5–11. doi: 10.1097/00004836-198606001-00003. [DOI] [PubMed] [Google Scholar]
  40. Hirschowitz B. I. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 1991 Nov;101(5):1149–1158. doi: 10.1016/0016-5085(91)90062-p. [DOI] [PubMed] [Google Scholar]
  41. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  42. Hotz J., Kleinert R., Grymbowski T., Hennig U., Schwarz J. A. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration. Aliment Pharmacol Ther. 1992 Feb;6(1):87–95. doi: 10.1111/j.1365-2036.1992.tb00548.x. [DOI] [PubMed] [Google Scholar]
  43. Hotz J., Plein K., Schönekäs H., Rose K. Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer. Scand J Gastroenterol. 1995 Feb;30(2):111–115. doi: 10.3109/00365529509093247. [DOI] [PubMed] [Google Scholar]
  44. Howden C. W., Hunt R. H. The relationship between suppression of acidity and gastric ulcer healing rates. Aliment Pharmacol Ther. 1990 Feb;4(1):25–33. doi: 10.1111/j.1365-2036.1990.tb00445.x. [DOI] [PubMed] [Google Scholar]
  45. Howden C. W., Jones D. B., Peace K. E., Burget D. W., Hunt R. H. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates. Dig Dis Sci. 1988 May;33(5):619–624. doi: 10.1007/BF01798367. [DOI] [PubMed] [Google Scholar]
  46. Hunt R. H., Cederberg C., Dent J., Halter F., Howden C., Marks I. N., Rune S., Walt R. P. Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci. 1995 Feb;40(2 Suppl):24S–49S. doi: 10.1007/BF02214870. [DOI] [PubMed] [Google Scholar]
  47. Hunt R. H., Malfertheiner P., Yeomans N. D., Hawkey C. J., Howden C. W. Critical issues in the pathophysiology and management of peptic ulcer disease. Eur J Gastroenterol Hepatol. 1995 Jul;7(7):685–699. [PubMed] [Google Scholar]
  48. Hunt R. H. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1995;9 (Suppl 1):3–7. doi: 10.1111/j.1365-2036.1995.tb00777.x. [DOI] [PubMed] [Google Scholar]
  49. Hunt R. H. pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism. Am J Gastroenterol. 1993 Apr;88(4):481–483. [PubMed] [Google Scholar]
  50. Ireland A., Colin-Jones D. G., Gear P., Golding P. L., Ramage J. K., Williams J. G., Leicester R. J., Smith C. L., Ross G., Bamforth J. Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers. Lancet. 1984 Aug 4;2(8397):274–276. doi: 10.1016/s0140-6736(84)90312-x. [DOI] [PubMed] [Google Scholar]
  51. Joelsson B., Johnsson F. Heartburn--the acid test. Gut. 1989 Nov;30(11):1523–1525. doi: 10.1136/gut.30.11.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Johansson K. E., Ask P., Boeryd B., Fransson S. G., Tibbling L. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1986 Sep;21(7):837–847. doi: 10.3109/00365528609011128. [DOI] [PubMed] [Google Scholar]
  53. Johnson L. F., Demeester T. R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974 Oct;62(4):325–332. [PubMed] [Google Scholar]
  54. Jones D. B., Howden C. W., Burget D. W., Kerr G. D., Hunt R. H. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut. 1987 Sep;28(9):1120–1127. doi: 10.1136/gut.28.9.1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. KINSELLA V. J. Pain in chronic gastric ulcer; basic anatomy and mechanism. Lancet. 1953 Aug 22;265(6782):353–360. doi: 10.1016/s0140-6736(53)91400-7. [DOI] [PubMed] [Google Scholar]
  56. KIRILUK L. B., MERENDINO K. A. The comparative sensitivity of the mucosa of the various segments of the alimentary tract in the dog to acid-peptic action. Surgery. 1954 Apr;35(4):547–556. [PubMed] [Google Scholar]
  57. Kang J. Y. Duodenal ulcer pain--the role of acid and inflammation. Gut. 1994 Jun;35(6):863–864. doi: 10.1136/gut.35.6.863-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Kang J. Y., Yap I., Guan R., Tay H. H. Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study. Gut. 1986 Aug;27(8):942–945. doi: 10.1136/gut.27.8.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Kang J. Y., Yap I., Guan R., Tay H. H., Math M. V. Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic. Gut. 1989 Feb;30(2):166–170. doi: 10.1136/gut.30.2.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kauer W. K., Burdiles P., Ireland A. P., Clark G. W., Peters J. H., Bremner C. G., DeMeester T. R. Does duodenal juice reflux into the esophagus of patients with complicated GERD? Evaluation of a fiberoptic sensor for bilirubin. Am J Surg. 1995 Jan;169(1):98–104. doi: 10.1016/s0002-9610(99)80116-0. [DOI] [PubMed] [Google Scholar]
  61. Kruse-Andersen S., Wallin L., Madsen T. Reflux patterns and related oesophageal motor activity in gastro-oesophageal reflux disease. Gut. 1990 Jun;31(6):633–638. doi: 10.1136/gut.31.6.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Lanzon-Miller S., Pounder R. E., Hamilton M. R., Ball S., Chronos N. A., Raymond F., Olausson M., Cederberg C. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther. 1987 Jun;1(3):239–251. doi: 10.1111/j.1365-2036.1987.tb00623.x. [DOI] [PubMed] [Google Scholar]
  63. Lanzon-Miller S., Pounder R. E., Hamilton M. R., Ball S., Chronos N. A., Raymond F., Olausson M., Cederberg C. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther. 1987 Jun;1(3):239–251. doi: 10.1111/j.1365-2036.1987.tb00623.x. [DOI] [PubMed] [Google Scholar]
  64. Lanzon-Miller S., Pounder R. E., Hamilton M. R., Chronos N. A., Ball S., Mercieca J. E., Olausson M., Cederberg C. Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther. 1987 Jun;1(3):225–237. doi: 10.1111/j.1365-2036.1987.tb00622.x. [DOI] [PubMed] [Google Scholar]
  65. Lee F. I., Reed P. I., Crowe J. P., McIsaac R. L., Wood J. R. Acute treatment of duodenal ulcer: a multicentre study to compare ranitidine 150 mg twice daily with ranitidine 300 mg once at night. Gut. 1986 Sep;27(9):1091–1095. doi: 10.1136/gut.27.9.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Little A. G., DeMeester T. R., Rezai-Zadeh K., Skinner D. B. Abnormal gastric emptying in patients with gastroesophageal reflux. Surg Forum. 1977;28:347–348. [PubMed] [Google Scholar]
  67. Londong W. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Aliment Pharmacol Ther. 1994;8 (Suppl 1):39–46. doi: 10.1111/j.1365-2036.1994.tb00239.x. [DOI] [PubMed] [Google Scholar]
  68. Lundell L., Backman L., Ekström P., Enander L. K., Falkmer S., Fausa O., Grimelius L., Havu N., Lind T., Lönroth H. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol. 1991 Mar;26(3):248–256. doi: 10.3109/00365529109025038. [DOI] [PubMed] [Google Scholar]
  69. Matikainen M. Gastric acid secretion, oesophageal acid reflux, and oesophagitis in patients with symptomatic gastro-oesophageal reflux. Scand J Gastroenterol. 1981;16(8):1043–1048. doi: 10.3109/00365528109181026. [DOI] [PubMed] [Google Scholar]
  70. McCloy R., Nair R. Surgery for acid suppression in the 1990s. Baillieres Clin Gastroenterol. 1993 Mar;7(1):129–148. doi: 10.1016/0950-3528(93)90034-p. [DOI] [PubMed] [Google Scholar]
  71. McColl K. E., Fullarton G. M., Chittajalu R., el Nujumi A. M., MacDonald A. M., Dahill S. W., Hilditch T. E. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol. 1991 Mar;26(3):339–346. doi: 10.3109/00365529109025052. [DOI] [PubMed] [Google Scholar]
  72. McColl K. E., Fullarton G. M. Duodenal ulcer pain--the role of acid and inflammation. Gut. 1993 Oct;34(10):1300–1302. doi: 10.1136/gut.34.10.1300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Merki H. S., Fimmel C. J., Walt R. P., Harre K., Röhmel J., Witzel L. Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls. Gut. 1988 Nov;29(11):1583–1587. doi: 10.1136/gut.29.11.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Michel P., Lemaire M., Colin R., Bommelaer G., Rambaud J. C., Dupas J. L., Bigard M. A., Verwaerd J. C. Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial. Aliment Pharmacol Ther. 1994 Feb;8(1):119–122. doi: 10.1111/j.1365-2036.1994.tb00167.x. [DOI] [PubMed] [Google Scholar]
  75. Moore J. G., Englert E., Jr Circadian rhythm of gastric acid secretion in man. Nature. 1970 Jun 27;226(5252):1261–1262. doi: 10.1038/2261261a0. [DOI] [PubMed] [Google Scholar]
  76. Muller M. J., Hunt R. H. Inflammation, acid and ulcers. Yale J Biol Med. 1994 May-Aug;67(3-4):135–144. [PMC free article] [PubMed] [Google Scholar]
  77. Mössner J., Hölscher A. H., Herz R., Schneider A. A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial. Aliment Pharmacol Ther. 1995 Jun;9(3):321–326. doi: 10.1111/j.1365-2036.1995.tb00388.x. [DOI] [PubMed] [Google Scholar]
  78. Orlando R. C., Bozymski E. M. Heartburn in pernicious anemia--a consequence of bile reflux. N Engl J Med. 1973 Sep 6;289(10):522–523. doi: 10.1056/NEJM197309062891008. [DOI] [PubMed] [Google Scholar]
  79. Pounder R. E., Fraser A. G. Gastric acid secretion and intragastric acidity: measurement in health and disease. Baillieres Clin Gastroenterol. 1993 Mar;7(1):55–80. doi: 10.1016/0950-3528(93)90031-m. [DOI] [PubMed] [Google Scholar]
  80. Poynard T., Lemaire M., Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. 1995 Jul;7(7):661–665. [PubMed] [Google Scholar]
  81. Prewett E. J., Smith J. T., Nwokolo C. U., Hudson M., Sawyerr A. M., Pounder R. E. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther. 1991 Jun;5(3):283–290. doi: 10.1111/j.1365-2036.1991.tb00029.x. [DOI] [PubMed] [Google Scholar]
  82. Robertson D., Aldersley M., Shepherd H., Smith C. L. Patterns of acid reflux in complicated oesophagitis. Gut. 1987 Nov;28(11):1484–1488. doi: 10.1136/gut.28.11.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Robinson M., Campbell D. R., Sontag S., Sabesin S. M. Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Dig Dis Sci. 1995 Mar;40(3):590–597. doi: 10.1007/BF02064376. [DOI] [PubMed] [Google Scholar]
  84. Roufail W., Belsito A., Robinson M., Barish C., Rubin A. Ranitidine for erosive oesophagitis: a double-blind, placebo-controlled study. Glaxo Erosive Esophagitis Study Group. Aliment Pharmacol Ther. 1992 Oct;6(5):597–607. doi: 10.1111/j.1365-2036.1992.tb00574.x. [DOI] [PubMed] [Google Scholar]
  85. Schepp W., Rehner M., Witzel L. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole. Aliment Pharmacol Ther. 1994;8 (Suppl 1):53–57. doi: 10.1111/j.1365-2036.1994.tb00253.x. [DOI] [PubMed] [Google Scholar]
  86. Schindlbeck N. E., Heinrich C., König A., Dendorfer A., Pace F., Müller-Lissner S. A. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology. 1987 Jul;93(1):85–90. doi: 10.1016/0016-5085(87)90318-0. [DOI] [PubMed] [Google Scholar]
  87. Seppälä K., Färkkilä M., Nuutinen H., Hakala K., Vänänen H., Rautelin H., Kosunen T. U. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol. 1992 Nov;27(11):973–976. doi: 10.3109/00365529209000173. [DOI] [PubMed] [Google Scholar]
  88. Shamburek R. D., Schubert M. L. Pharmacology of gastric acid inhibition. Baillieres Clin Gastroenterol. 1993 Mar;7(1):23–54. doi: 10.1016/0950-3528(93)90030-v. [DOI] [PubMed] [Google Scholar]
  89. Smith J. L., Opekun A. R., Larkai E., Graham D. Y. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 1989 Mar;96(3):683–689. [PubMed] [Google Scholar]
  90. Sonnenberg A., Müller-Lissner S. A., Vogel E., Schmid P., Gonvers J. J., Peter P., Strohmeyer G., Blum A. L. Predictors of duodenal ulcer healing and relapse. Gastroenterology. 1981 Dec;81(6):1061–1067. [PubMed] [Google Scholar]
  91. Sontag S. J. Rolling review: gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1993 Jun;7(3):293–312. doi: 10.1111/j.1365-2036.1993.tb00101.x. [DOI] [PubMed] [Google Scholar]
  92. Sung J. J., Chung S. C., Ling T. K., Yung M. Y., Leung V. K., Ng E. K., Li M. K., Cheng A. F., Li A. K. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med. 1995 Jan 19;332(3):139–142. doi: 10.1056/NEJM199501193320302. [DOI] [PubMed] [Google Scholar]
  93. Tatsuta M., Iishi H., Yokota Y. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. Am J Gastroenterol. 1995 Mar;90(3):406–410. [PubMed] [Google Scholar]
  94. Tatsuta M., Ishikawa H., Iishi H., Okuda S., Yokota Y. Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime. Gut. 1990 Sep;31(9):973–976. doi: 10.1136/gut.31.9.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Valenzuela J. E., Berlin R. G., Snape W. J., Johnson T. L., Hirschowitz B. I., Colon-Pagan J., Morse R. S., Petrozza J., Van Deventer G. M., Cagliola A. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group. Dig Dis Sci. 1991 Jun;36(6):761–768. doi: 10.1007/BF01311234. [DOI] [PubMed] [Google Scholar]
  96. Walan A., Bader J. P., Classen M., Lamers C. B., Piper D. W., Rutgersson K., Eriksson S. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med. 1989 Jan 12;320(2):69–75. doi: 10.1056/NEJM198901123200201. [DOI] [PubMed] [Google Scholar]
  97. de Caestecker J. S., Blackwell J. N., Pryde A., Heading R. C. Daytime gastro-oesophageal reflux is important in oesophagitis. Gut. 1987 May;28(5):519–526. doi: 10.1136/gut.28.5.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. el-Omar E. M., Penman I. D., Ardill J. E., Chittajallu R. S., Howie C., McColl K. E. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 1995 Sep;109(3):681–691. doi: 10.1016/0016-5085(95)90374-7. [DOI] [PubMed] [Google Scholar]
  99. el-Omar E., Penman I., Dorrian C. A., Ardill J. E., McColl K. E. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut. 1993 Aug;34(8):1060–1065. doi: 10.1136/gut.34.8.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES